- Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B
-
Eun JR
- KMID: 760645
- Korean J Hepatol.
- 2006 Jun;12(2):184-190.
BACKGROUNDS/AIMS: Continuation of lamivudine therapy is controversial for patients with chronic hepatitis B when viral breakthrough occurs. Moreover, the effect of continuous lamivudine therapy is unknown in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant
-
Kim JK, Hwang SG, Park H, Choi HY, Cho HJ, Ko KH, Hong SP, Park PW, Kim NK, Rim KS
- KMID: 760605
- Korean J Hepatol.
- 2005 Sep;11(3):227-242.
BACKGROUND/AIMS: The therapeutic strategies of applying adefovir for treating lamivudine resistant HBV mutants are controversial. Thus, we observed the clinical outcomes after discontinuation of lamivudine to establish the timing... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naive Patients with HBeAg Positive Chronic Hepatitis B
-
Kim IH, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Choi CS, Kim HC
- KMID: 1713959
- J Korean Med Sci.
- 2010 May;25(5):738-745.
- doi: 10.3346/jkms.2010.25.5.738
The authors assessed the efficacy and antiviral resistance of 48-week clevudine therapy versus lamivudine in treatment of naive patients with HBeAg positive chronic hepatitis B. In this retrospective study, a... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Efficacy of Clevudine, Entecavir and Lamivudine in Treatment-naive Patients with HBeAg-Positive Chronic Hepatitis B
-
Bae SH, Baek YH, Lee SW, Han SY
- KMID: 1775852
- Korean J Gastroenterol.
- 2010 Dec;56(6):365-372.
- doi: 10.4166/kjg.2010.56.6.365
BACKGROUND/AIMS: Clevudine is a potent antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. This study compared the efficacy of clevudine (C), entecavir (E) and lamivudine (L)... -
- CITED
-
- Close
- SHARE
-
- Close
